These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 24563457)

  • 1. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
    Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
    Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive malfunctions of calmodulin mutations associated with heart RyR2-mediated arrhythmic disease.
    Vassilakopoulou V; Calver BL; Thanassoulas A; Beck K; Hu H; Buntwal L; Smith A; Theodoridou M; Kashir J; Blayney L; Livaniou E; Nounesis G; Lai FA; Nomikos M
    Biochim Biophys Acta; 2015 Nov; 1850(11):2168-76. PubMed ID: 26164367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Gao J; Makiyama T; Yamamoto Y; Kobayashi T; Aoki H; Maurissen TL; Wuriyanghai Y; Kashiwa A; Imamura T; Aizawa T; Huang H; Kohjitani H; Nishikawa M; Chonabayashi K; Fukuyama M; Manabe H; Nakau K; Wada T; Kato K; Toyoda F; Yoshida Y; Makita N; Woltjen K; Ohno S; Kurebayashi N; Murayama T; Sakurai T; Horie M; Kimura T
    Circ Arrhythm Electrophysiol; 2023 Mar; 16(3):e011387. PubMed ID: 36866681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.
    Søndergaard MT; Liu Y; Larsen KT; Nani A; Tian X; Holt C; Wang R; Wimmer R; Van Petegem F; Fill M; Chen SR; Overgaard MT
    J Biol Chem; 2017 Jan; 292(4):1385-1395. PubMed ID: 27927985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms.
    Yin G; Hassan F; Haroun AR; Murphy LL; Crotti L; Schwartz PJ; George AL; Satin J
    J Am Heart Assoc; 2014 Jun; 3(3):e000996. PubMed ID: 24958779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks.
    Gomez-Hurtado N; Boczek NJ; Kryshtal DO; Johnson CN; Sun J; Nitu FR; Cornea RL; Chazin WJ; Calvert ML; Tester DJ; Ackerman MJ; Knollmann BC
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.
    Søndergaard MT; Tian X; Liu Y; Wang R; Chazin WJ; Chen SR; Overgaard MT
    J Biol Chem; 2015 Oct; 290(43):26151-62. PubMed ID: 26309258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Transfer of Engineered Calmodulin Alleviates Ventricular Arrhythmias in a Calsequestrin-Associated Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Liu B; Walton SD; Ho HT; Belevych AE; Tikunova SB; Bonilla I; Shettigar V; Knollmann BC; Priori SG; Volpe P; Radwański PB; Davis JP; Györke S
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Biochemical Properties and Disparate Impact of Arrhythmogenic Calmodulin Mutations on Zebrafish Cardiac Function.
    Da'as SI; Thanassoulas A; Calver BL; Saleh A; Abdelrahman D; Hasan W; Safieh-Garabedian B; Kontogianni I; Nasrallah GK; Nounesis G; Lai FA; Nomikos M
    J Cell Biochem; 2024 Aug; 125(8):e30619. PubMed ID: 38946237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.
    Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor.
    Holt C; Hamborg L; Lau K; Brohus M; Sørensen AB; Larsen KT; Sommer C; Van Petegem F; Overgaard MT; Wimmer R
    J Biol Chem; 2020 May; 295(22):7620-7634. PubMed ID: 32317284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced binding of calmodulin to RyR2 corrects arrhythmogenic channel disorder in CPVT-associated myocytes.
    Fukuda M; Yamamoto T; Nishimura S; Kato T; Murakami W; Hino A; Ono M; Tateishi H; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
    Biochem Biophys Res Commun; 2014 May; 448(1):1-7. PubMed ID: 24755079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.
    Hilliard FA; Steele DS; Laver D; Yang Z; Le Marchand SJ; Chopra N; Piston DW; Huke S; Knollmann BC
    J Mol Cell Cardiol; 2010 Feb; 48(2):293-301. PubMed ID: 19835880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenic calmodulin E105A mutation alters cardiac RyR2 regulation leading to cardiac dysfunction in zebrafish.
    Da'as SI; Thanassoulas A; Calver BL; Beck K; Salem R; Saleh A; Kontogianni I; Al-Maraghi A; Nasrallah GK; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Ann N Y Acad Sci; 2019 Jul; 1448(1):19-29. PubMed ID: 30937913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure.
    Yang Y; Guo T; Oda T; Chakraborty A; Chen L; Uchinoumi H; Knowlton AA; Fruen BR; Cornea RL; Meissner G; Bers DM
    Circ Res; 2014 Jan; 114(2):295-306. PubMed ID: 24186966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
    Savio-Galimberti E; Knollmann BC
    PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation-linked, excessively tight interaction between the calmodulin binding domain and the C-terminal domain of the cardiac ryanodine receptor as a novel cause of catecholaminergic polymorphic ventricular tachycardia.
    Nishimura S; Yamamoto T; Nakamura Y; Kohno M; Hamada Y; Sufu Y; Fukui G; Nanno T; Ishiguchi H; Kato T; Xu X; Ono M; Oda T; Okuda S; Kobayashi S; Yano M
    Heart Rhythm; 2018 Jun; 15(6):905-914. PubMed ID: 29427818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.
    Nakamura Y; Yamamoto T; Kobayashi S; Tamitani M; Hamada Y; Fukui G; Xu X; Nishimura S; Kato T; Uchinoumi H; Oda T; Okuda S; Yano M
    JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished inhibition and facilitated activation of RyR2-mediated Ca
    Søndergaard MT; Liu Y; Brohus M; Guo W; Nani A; Carvajal C; Fill M; Overgaard MT; Chen SRW
    FEBS J; 2019 Nov; 286(22):4554-4578. PubMed ID: 31230402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.